Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Havelund

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Gastroenterology|March 1, 1991
Omeprazole 20 mg three days a week and 10 mg daily in prevention of duodenal ulcer relapse. Double-blind comparative trialK Lauritsen, B N Andersen, L S Laursen, et al.
Scandinavian Journal of Gastroenterology|April 1, 1997
Effect of omeprazole on the outcome of endoscopically treated bleeding peptic ulcers. Randomized double-blind placebo-controlled multicentre studyO B Schaffalitzky de Muckadell, T Havelund, H Harling, et al.
British Medical Journal (Clinical Research Ed.)|January 9, 1988
Omeprazole and ranitidine in treatment of reflux oesophagitis: double blind comparative trialT Havelund, L S Laursen, E Skoubo-Kristensen, et al.
Alimentary Pharmacology & Therapeutics|June 26, 1999
On demand therapy with omeprazole for the long-term management of patients with heartburn without oesophagitis--a placebo-controlled randomized trialT Lind, T Havelund, L Lundell, et al.
Gut|February 1, 1988
Effect of omeprazole and cimetidine on prepyloric gastric ulcer: double blind comparative trialK Lauritsen, S J Rune, H R Wulff, et al.
Scandinavian Journal of Gastroenterology|November 15, 1997
Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic responseT Lind, T Havelund, R Carlsson, et al.
Allergy|June 30, 2017
Omalizumab prevents anaphylaxis and improves symptoms in systemic mastocytosis: Efficacy and safety observationsS Broesby-Olsen, H Vestergaard, C G Mortz, et al.
The American Journal of Gastroenterology|July 16, 1999
Quality of life in patients with heartburn but without esophagitis: effects of treatment with omeprazoleT Havelund, T Lind, I Wiklund, et al.
Scandinavian Journal of Gastroenterology|January 14, 2003
Effect of profound acid suppression in functional dyspepsia: a double-blind, randomized, placebo-controlled trialE Bolling-Sternevald, K Lauritsen, C Aalykke, et al.
Endoscopy|May 9, 2008
Small-bowel neoplasms in patients undergoing video capsule endoscopy: a multicenter European studyE Rondonotti, M Pennazio, E Toth, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Gastroenterology|March 1, 1991
Omeprazole 20 mg three days a week and 10 mg daily in prevention of duodenal ulcer relapse. Double-blind comparative trialK Lauritsen, B N Andersen, L S Laursen, et al.
Scandinavian Journal of Gastroenterology|April 1, 1997
Effect of omeprazole on the outcome of endoscopically treated bleeding peptic ulcers. Randomized double-blind placebo-controlled multicentre studyO B Schaffalitzky de Muckadell, T Havelund, H Harling, et al.
British Medical Journal (Clinical Research Ed.)|January 9, 1988
Omeprazole and ranitidine in treatment of reflux oesophagitis: double blind comparative trialT Havelund, L S Laursen, E Skoubo-Kristensen, et al.
Alimentary Pharmacology & Therapeutics|June 26, 1999
On demand therapy with omeprazole for the long-term management of patients with heartburn without oesophagitis--a placebo-controlled randomized trialT Lind, T Havelund, L Lundell, et al.
Gut|February 1, 1988
Effect of omeprazole and cimetidine on prepyloric gastric ulcer: double blind comparative trialK Lauritsen, S J Rune, H R Wulff, et al.
Scandinavian Journal of Gastroenterology|November 15, 1997
Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic responseT Lind, T Havelund, R Carlsson, et al.
Allergy|June 30, 2017
Omalizumab prevents anaphylaxis and improves symptoms in systemic mastocytosis: Efficacy and safety observationsS Broesby-Olsen, H Vestergaard, C G Mortz, et al.
The American Journal of Gastroenterology|July 16, 1999
Quality of life in patients with heartburn but without esophagitis: effects of treatment with omeprazoleT Havelund, T Lind, I Wiklund, et al.
Scandinavian Journal of Gastroenterology|January 14, 2003
Effect of profound acid suppression in functional dyspepsia: a double-blind, randomized, placebo-controlled trialE Bolling-Sternevald, K Lauritsen, C Aalykke, et al.
Endoscopy|May 9, 2008
Small-bowel neoplasms in patients undergoing video capsule endoscopy: a multicenter European studyE Rondonotti, M Pennazio, E Toth, et al.
Pageof 3